We are live on ! Find out more
TPCW

TD Private Client Wealth Portfolio holdings

AUM $4.82B
1-Year Est. Return 15.21%
This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+15.21%
3 Year Est. Return
+48.23%
5 Year Est. Return
+55.79%
10 Year Est. Return
AUM
$3.18B
AUM Growth
+$129M
Cap. Flow
+$96.5M
Cap. Flow %
3.04%
Top 10 Hldgs %
33.87%
Holding
1,277
New
61
Increased
526
Reduced
484
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 8.27%
2 Financials 4.79%
3 Healthcare 4.45%
4 Industrials 3.33%
5 Communication Services 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMB icon
1101
Trimble
TRMB
$11.7B
$4.03K ﹤0.01%
72
-18
-20% -$1.04K
PCY icon
1102
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$4K ﹤0.01%
200
+74
+59% +$1.49K
CERT icon
1103
Certara
CERT
$1.11B
$3.96K ﹤0.01%
286
+70
+32% +$1.15K
EWJ icon
1104
iShares MSCI Japan ETF
EWJ
$21.7B
$3.96K ﹤0.01%
58
CC icon
1105
Chemours
CC
$2.63B
$3.84K ﹤0.01%
170
HRL icon
1106
Hormel Foods
HRL
$13.8B
$3.63K ﹤0.01%
119
+92
+341% +$3.09K
DAR icon
1107
Darling Ingredients
DAR
$10.1B
$3.6K ﹤0.01%
98
-237
-71% -$9.83K
LNC icon
1108
Lincoln National
LNC
$7.81B
$3.51K ﹤0.01%
113
INCY icon
1109
Incyte
INCY
$23.3B
$3.33K ﹤0.01%
55
-292
-84% -$16.5K
KRG icon
1110
Kite Realty
KRG
$5.87B
$3.31K ﹤0.01%
148
CMBT
1111
CMB.TECH NV
CMBT
$4.53B
$3.27K ﹤0.01%
198
LYG icon
1112
Lloyds Banking Group
LYG
$87B
$3.22K ﹤0.01%
1,178
+701
+147% +$1.88K
CERE
1113
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$3.19K ﹤0.01%
+78
New +$3.25K
TXRH icon
1114
Texas Roadhouse
TXRH
$12.5B
$3.09K ﹤0.01%
18
+7
+64% +$1.14K
BUD icon
1115
AB InBev
BUD
$155B
$3.08K ﹤0.01%
53
+27
+104% +$1.65K
TAK icon
1116
Takeda Pharmaceutical
TAK
$53.7B
$3.08K ﹤0.01%
238
+123
+107% +$1.63K
AZTA icon
1117
Azenta
AZTA
$1.3B
$2.89K ﹤0.01%
55
-89
-62% -$4.76K
IX icon
1118
ORIX
IX
$43.8B
$2.89K ﹤0.01%
130
+75
+136% +$1.6K
FRPT icon
1119
Freshpet
FRPT
$2.78B
$2.85K ﹤0.01%
22
-3
-12% -$360
OHI icon
1120
Omega Healthcare
OHI
$15.2B
$2.77K ﹤0.01%
81
TEVA icon
1121
Teva Pharmaceuticals
TEVA
$36.3B
$2.71K ﹤0.01%
167
+133
+391% +$2.05K
RWO icon
1122
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.29B
$2.66K ﹤0.01%
64
EDV icon
1123
Vanguard World Funds Extended Duration ETF
EDV
$3.3B
$2.64K ﹤0.01%
36
DB icon
1124
Deutsche Bank
DB
$65.3B
$2.61K ﹤0.01%
164
+124
+310% +$2.03K
BCS icon
1125
Barclays
BCS
$93.3B
$2.48K ﹤0.01%
232
+159
+218% +$1.65K

Similar funds

TD Private Client Wealth's Q2 2024 Portfolio in Review

As of Q2 2024, TD Private Client Wealth held 1,277 positions worth $3.18B, up 4.2% from $3.05B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

TD Private Client Wealth deployed $96.5M of net new capital in Q2 2024, opening 61 new positions and adding to 526 existing holdings. Its largest new stake was State Street SPDR MSCI ACWI ex-US ETF: 10,674 shares worth $302K.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 8.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.71M trimmed.

  • TD Private Client Wealth's largest Q2 2024 buy was State Street SPDR MSCI ACWI ex-US ETF: 10,674 shares worth $302K.
  • TD Private Client Wealth added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2024, an estimated $22.2M increase.
  • TD Private Client Wealth's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.71M.
  • TD Private Client Wealth fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $722K.
  • TD Private Client Wealth's ten largest holdings make up 34% of its $3.18B portfolio in Q2 2024.
  • TD Private Client Wealth opened 61 new positions and closed 61 in Q2 2024.
  • TD Private Client Wealth's portfolio value rose 4.2% quarter-over-quarter to $3.18B.

Based on TD Private Client Wealth's 13F filing for Q2 2024, filed 14 Aug 2024.